US equities |
META $620.19 ▼-1.64% MU $928.76 ▲+2.77% NVDA $217.94 ▲+0.90% TSLA $407.46 ▲+4.04% SPCX $148.58 ▲+1.14% AAPL $347.10 ▲+0.93% AMD $560.26 ▲+5.45% MSFT $531.33 ▼-0.24%
FinancialContent

Schrodinger, Inc. - Common Stock (NQ:SDGR)

26.72 +2.22 (+9.06%)
Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4
From Schrödinger
Via Business Wire
News headline image
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
AI Found an Influenza Target That Survives Viral Mutation
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) 
From Equity Insider
Via GlobeNewswire
News headline image
Schrödinger Reports Second Quarter 2026 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
From Schrödinger
Via Business Wire
News headline image
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports First Quarter 2026 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Participate in Upcoming Investor Conferences
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Participate in Upcoming Investor Conferences
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
From Schrödinger
Via Business Wire
News headline image
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
From Schrödinger
Via Business Wire
News headline image
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Present at Jefferies London Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Third Quarter 2025 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5
From Schrödinger
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >